By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Novuspharma SpA 

Viale G.B. Stucchi 110

Monza      Italy
Phone: 39-039-2814-1 Fax: +39-039-2814-601


SEARCH JOBS


Industry
Biotechnology






Company News
Novuspharma SpA (IT:NOV) Release: Pixantrone Research Study Reveals No Increase In Anthracycline-Induced Heart Damage10/19/2005 5:10:49 PM
Novuspharma SpA (IT:NOV) Release: Study Reveals No Increase In Anthracycline-Induced Heart Damage With Pixantrone10/19/2005 5:10:49 PM
Novuspharma SpA (IT:NOV) Release: Impressive Data For Pixantrone In The CHOP-Variant Regimen To Be Presented At The 2003 American Society Of Haematology (ASH) Meeting10/19/2005 5:10:28 PM
Cell Therapeutics (CTIC) And Novuspharma SpA (IT:NOV) Complete Merger10/19/2005 5:09:35 PM
Commissione Nazionale Per Le Societa E La Borsa (Consob) Approves Prospectus For Listing Cell Therapeutics (CTIC) On The Nuovo Mercato10/19/2005 5:09:34 PM
Novuspharma SpA (IT:NOV) Release: Pixantrone Induces Impressive 77% Major Tumor Response Rate In Patients With Relapsed Aggressive Lymphoma When Substituted For Doxorubicin In CHOP Regimen10/19/2005 5:09:28 PM
KPMG S.p.A. Says It Was Not Independent With Respect To Novuspharma SpA (IT:NOV)10/19/2005 5:08:59 PM
//-->